Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
937P Multicenter phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD — Masafumi Ikeda (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
937P Multicenter phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD
Shared by
Masatoshi Kudo
937P Multicenter phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD
Article
2021
en
Authors
+13 more
MI
Masafumi Ikeda
TY
Tatsuya Yamashita
SO
Sadahisa Ogasawara
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2023
Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD
Masafumi Ikeda
,
Tatsuya Yamashita
,
Sadahisa Ogasawara
,
Masatoshi Kudo
,
Yoshitaka Inaba
,
Manabu Morimoto
,
Kaoru Tsuchiya
,
Satoshi Shimizu
,
Yasushi Kojima
,
Atsushi Hiraoka
,
Kazuhiro Nouso
,
Hiroshi Aikata
,
Kazushi Numata
,
Tosiya Sato
,
Takuji Okusaka
,
Junji Furuse
Dataset
Supplementary Material for: Multicenter Phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD
Masafumi Ikeda
,
Tatsuya Yamashita
,
Sadahisa Ogasawara
,
Masatoshi Kudo
,
Yoshitaka Inaba
,
Manabu Morimoto
,
Kaoru Tsuchiya
,
Shinichi Shimizu
,
Yasushi Kojima
,
Atsushi Hiraoka
,
Kazuhiro Nouso
,
Hiroshi Aikata
,
Kazushi Numata
,
Tosiya Sato
,
Takuji Okusaka
,
Junji Furuse
Article
2016
Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
M. Ikeda
,
Satoshi Shimizu
,
Tosiya Sato
,
Manabu Morimoto
,
Yasushi Kojima
,
Yoshitaka Inaba
,
Atsushi Hagihara
,
Masatoshi Kudo
,
Shoji Nakamori
,
Shuichi Kaneko
,
Rie Sugimoto
,
T. Tahara
,
Takumi Ohmura
,
K. Yasui
,
Kiyoshi Sato
,
Hiroshi Ishii
,
Junji Furuse
,
Takuji Okusaka
Article
2015
Sorafenib plus intra-arterial cisplatin versus sorafenib alone in patients with advanced hepatocellular carcinoma: A randomized phase II trial.
Masafumi Ikeda
,
Satoshi Shimizu
,
Tosiya Sato
,
Manabu Morimoto
,
Yoshitaka Inaba
,
Yasushi Kojima
,
Atsushi Hagihara
,
Masatoshi Kudo
,
Shoji Nakamori
,
Shuichi Kaneko
,
Rie Sugimoto
,
Toshiyuki Tahara
,
Takumi Ohmura
,
Kohichiroh Yasui
,
Keiko Sato
,
Hiroshi Ishii
,
Junji Furuse
,
Takuji Okusaka
Article
2020
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Kazuomi Ueshima
,
Sadahisa Ogasawara
,
Masafumi Ikeda
,
Yutaka Yasui
,
Takeshi Terashima
,
Tatsuya Yamashita
,
Shuntaro Obi
,
Shinpei Sato
,
Hiroshi Aikata
,
Takumi Ohmura
,
Hidekatsu Kuroda
,
Takamasa Ohki
,
Kengo Nagashima
,
Yoshihiko Ooka
,
Masahiro Takita
,
Masayuki Kurosaki
,
Kazuaki Chayama
,
Shuichi Kaneko
,
Namiki Izumi
,
Naoya Kato
,
Masatoshi Kudo
,
Masao Omata
Discussion(0)
No comments yet. Be the first to comment.